JGCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
J.G. Chemicals Limited held its Board meeting on May 14, 2026, approving the audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026. Standalone revenue stood at ₹2,889.48 million with net profit of ₹214.50 million, while consolidated revenue was ₹9,729.30 million with net profit of ₹173.10 million. The Board recommended a final dividend of 11% (₹1.10 per share) for FY 2025-26, subject to shareholder approval. All three auditors (Cost, Internal, and Tax) were reappointed for FY 2026-2027. The company also disclosed that ₹42.62 million of IPO proceeds meant for R&D Centre setup remains unutilized due to delays in construction and equipment procurement, with deployment now extended to FY 2027. Total IPO utilization stands at ₹1,161.92 million out of ₹1,493.24 million raised.
Positive signals include strong revenue growth, clean audit opinions, and shareholder-friendly dividend. The R&D Centre fund extension warrants monitoring as it indicates slower-than-expected capex deployment.